CLINICAL_TRIALS
trial_result
· 2010-03-26
Clinical Trial Update: Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy [Phase 2]
Summary
Phase 2 study evaluating cetuximab added to chemoradiotherapy for nasopharyngeal carcinoma; the trial completed and results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2010-03-26